BACKGROUND: Glucose-dependent insulinotropic peptide (GIP) provides a novel link between the immune system and the gut, although results from different experimental and observational studies are contradictory, ranging from anti-inflammatory, through neutral to pro-inflammatory action of GIP. Thus, the aim of this study was to analyze inflammatory pathways on the level of gene expression and circulating inflammatory markers in relation to plasma GIP level. SUBJECTS/ METHODS: The study included 128 obese adults. Two groups of obese subjects were created according to fasting GIP levels, with cutoff point at the 66th percentile and compared in respect with molecular and circulating markers of inflammation. GIP, interleukin (IL)-6 and adipokines: leptin, adiponectin, visfatin were measured by enzyme-linked immunosorbent assay. Inflammatory markers: monocyte chemoattractant protein-1 (MCP-1), sE-Selectin, sVCAM-1, sPECAM-1 were studied at fasting and after nutrient challenges. Gene expression in blood cells was determined by human gene microarray. RESULTS: Obese patients with high GIP levels had elevated fasting glucose (Q2 (Q1-Q3): 5.6 (5.0-6.0) vs 5.0 (4.8-5.4), P<0.001), homeostasis model assessment of insulin resistance (Q2 (Q1-Q3): 3.68 (2.72-5.42) vs 2.70 (2.13-4.33), P=0.021), thus increased markers of insulin resistance as well as elevated inflammatory markers Il-6 (Q2 (Q1-Q3): 1.34 (1.0-2.04) vs 1.12 (0.76-1.64), P=0.045), MCP-1 (Q2 (Q1-Q3): 363 (287-447) vs 323 (263-389), P=0.026). Leptin to adiponectin ratio was significantly associated with fasting plasma GIP levels (β (95% CI): 0.84 (0.10-1.59)) independently of glucose levels. sE-Selectin was found to be a factor influencing GIP response to oral glucose intake (β (95% CI): 0.47 (0.14-0.81)) and sVCAM was found to be a factor influencing GIP response to high-fat meal intake (β (95% CI): 0.19 (0.01-0.37)). We identified 32 genes of inflammatory pathways differentially expressed in subjects with a high plasma GIP level compared to low GIP. Most upregulated genes play a role in leukocyte chemotaxis and tissue infiltration. CONCLUSIONS: These findings support the hypothesis that increased GIP signaling has a role in chronic low-grade inflammation.
BACKGROUND:Glucose-dependent insulinotropic peptide (GIP) provides a novel link between the immune system and the gut, although results from different experimental and observational studies are contradictory, ranging from anti-inflammatory, through neutral to pro-inflammatory action of GIP. Thus, the aim of this study was to analyze inflammatory pathways on the level of gene expression and circulating inflammatory markers in relation to plasma GIP level. SUBJECTS/ METHODS: The study included 128 obese adults. Two groups of obese subjects were created according to fasting GIP levels, with cutoff point at the 66th percentile and compared in respect with molecular and circulating markers of inflammation. GIP, interleukin (IL)-6 and adipokines: leptin, adiponectin, visfatin were measured by enzyme-linked immunosorbent assay. Inflammatory markers: monocyte chemoattractant protein-1 (MCP-1), sE-Selectin, sVCAM-1, sPECAM-1 were studied at fasting and after nutrient challenges. Gene expression in blood cells was determined by human gene microarray. RESULTS:Obesepatients with high GIP levels had elevated fasting glucose (Q2 (Q1-Q3): 5.6 (5.0-6.0) vs 5.0 (4.8-5.4), P<0.001), homeostasis model assessment of insulin resistance (Q2 (Q1-Q3): 3.68 (2.72-5.42) vs 2.70 (2.13-4.33), P=0.021), thus increased markers of insulin resistance as well as elevated inflammatory markers Il-6 (Q2 (Q1-Q3): 1.34 (1.0-2.04) vs 1.12 (0.76-1.64), P=0.045), MCP-1 (Q2 (Q1-Q3): 363 (287-447) vs 323 (263-389), P=0.026). Leptin to adiponectin ratio was significantly associated with fasting plasma GIP levels (β (95% CI): 0.84 (0.10-1.59)) independently of glucose levels. sE-Selectin was found to be a factor influencing GIP response to oral glucose intake (β (95% CI): 0.47 (0.14-0.81)) and sVCAM was found to be a factor influencing GIP response to high-fat meal intake (β (95% CI): 0.19 (0.01-0.37)). We identified 32 genes of inflammatory pathways differentially expressed in subjects with a high plasma GIP level compared to low GIP. Most upregulated genes play a role in leukocyte chemotaxis and tissue infiltration. CONCLUSIONS: These findings support the hypothesis that increased GIP signaling has a role in chronic low-grade inflammation.
Authors: Se-Hyung Park; Zun Liu; Yipeng Sui; Robert N Helsley; Beibei Zhu; David K Powell; Philip A Kern; Changcheng Zhou Journal: Diabetes Date: 2016-03-18 Impact factor: 9.461
Authors: Sung Sik Choe; Jin Young Huh; In Jae Hwang; Jong In Kim; Jae Bum Kim Journal: Front Endocrinol (Lausanne) Date: 2016-04-13 Impact factor: 5.555
Authors: Kristen R Lednovich; Chioma Nnyamah; Sophie Gough; Medha Priyadarshini; Kai Xu; Barton Wicksteed; Sidharth Mishra; Shalini Jain; Joseph L Zapater; Hariom Yadav; Brian T Layden Journal: Am J Physiol Endocrinol Metab Date: 2022-07-20 Impact factor: 5.900
Authors: Jacqueline L Beaudry; Kiran D Kaur; Elodie M Varin; Laurie L Baggio; Xiemin Cao; Erin E Mulvihill; Holly E Bates; Jonathan E Campbell; Daniel J Drucker Journal: Mol Metab Date: 2019-08-10 Impact factor: 7.422
Authors: Gillian E Jacobsen; Irina Fernández; Maria A Quintero; Ana M Santander; Judith Pignac-Kobinger; Oriana M Damas; Amar R Deshpande; David H Kerman; Yuguang Ban; Zhen Gao; Tiago C Silva; Lily Wang; Ashley H Beecham; Jacob L McCauley; Juan F Burgueño; Maria T Abreu Journal: Gastro Hep Adv Date: 2022-03-30
Authors: Amra Jujić; Naeimeh Atabaki-Pasdar; Peter M Nilsson; Peter Almgren; Liisa Hakaste; Tiinamaija Tuomi; Lisa M Berglund; Paul W Franks; Jens J Holst; Rashmi B Prasad; Signe S Torekov; Susana Ravassa; Javier Díez; Margaretha Persson; Olle Melander; Maria F Gomez; Leif Groop; Emma Ahlqvist; Martin Magnusson Journal: Diabetologia Date: 2020-01-23 Impact factor: 10.122